CS264150B2 - Process for preparing new 1-/4-aminophenyl/-4-methyl-7,8-methylendioxy-3,4-dihydro-5h-2,3-benzodiazepine - Google Patents

Process for preparing new 1-/4-aminophenyl/-4-methyl-7,8-methylendioxy-3,4-dihydro-5h-2,3-benzodiazepine Download PDF

Info

Publication number
CS264150B2
CS264150B2 CS876007A CS600787A CS264150B2 CS 264150 B2 CS264150 B2 CS 264150B2 CS 876007 A CS876007 A CS 876007A CS 600787 A CS600787 A CS 600787A CS 264150 B2 CS264150 B2 CS 264150B2
Authority
CS
Czechoslovakia
Prior art keywords
hydride
formula
aminophenyl
compound
methyl
Prior art date
Application number
CS876007A
Other languages
Czech (cs)
English (en)
Other versions
CS600787A2 (en
Inventor
Jeno Dr Korosi
Tibor Dr Lang
Ferenc Dr Andrasi
Pal Dr Berzsenyi
Peter Botka
Tamas Hamori
Katalin Dr Goldschmidt
Jozsef Dr Borsy
Istvan Dr Elekes
Zsusza Dr Lang
Original Assignee
Biogal Gyogyszergyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogal Gyogyszergyar filed Critical Biogal Gyogyszergyar
Publication of CS600787A2 publication Critical patent/CS600787A2/cs
Publication of CS264150B2 publication Critical patent/CS264150B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
CS876007A 1986-08-15 1987-08-14 Process for preparing new 1-/4-aminophenyl/-4-methyl-7,8-methylendioxy-3,4-dihydro-5h-2,3-benzodiazepine CS264150B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU863594A HU198494B (en) 1986-08-15 1986-08-15 Process for producing new 3,4-dihydro-5h-2,3-benzodiazepine derivative and acid addition salts thereof, as well as pharmaceutical compositions comprising same

Publications (2)

Publication Number Publication Date
CS600787A2 CS600787A2 (en) 1988-08-16
CS264150B2 true CS264150B2 (en) 1989-06-13

Family

ID=10964707

Family Applications (1)

Application Number Title Priority Date Filing Date
CS876007A CS264150B2 (en) 1986-08-15 1987-08-14 Process for preparing new 1-/4-aminophenyl/-4-methyl-7,8-methylendioxy-3,4-dihydro-5h-2,3-benzodiazepine

Country Status (23)

Country Link
US (1) US4835152A (en, 2012)
JP (1) JPS6399073A (en, 2012)
AT (1) ATA202187A (en, 2012)
AU (1) AU596206B2 (en, 2012)
BE (1) BE1002415A4 (en, 2012)
CA (1) CA1284322C (en, 2012)
CH (1) CH673652A5 (en, 2012)
CS (1) CS264150B2 (en, 2012)
DD (1) DD265627A5 (en, 2012)
DE (1) DE3727226A1 (en, 2012)
DK (1) DK164555C (en, 2012)
ES (1) ES2004985A6 (en, 2012)
FI (1) FI85706C (en, 2012)
FR (1) FR2602773B1 (en, 2012)
GB (1) GB2194236B (en, 2012)
HU (1) HU198494B (en, 2012)
IT (1) IT1222508B (en, 2012)
NL (1) NL8701909A (en, 2012)
NO (1) NO164656C (en, 2012)
PL (1) PL148535B1 (en, 2012)
RU (1) RU1779251C (en, 2012)
SE (1) SE467357B (en, 2012)
YU (1) YU46223B (en, 2012)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU219778B (hu) * 1990-12-21 2001-07-30 Gyógyszerkutató Intézet Közös Vállalat Eljárás N-acil-2,3-benzodiazepin-származékok, savaddíciós sóik és az ezeket tartalmazó gyógyászati készítmények előállítására, valamint a vegyületek egy csoportja, és az ezeket tartalmazó gyógyászati készítmények
HU206719B (en) * 1990-12-21 1992-12-28 Gyogyszerkutato Intezet Process for producing 1-/4-acylamino-phenyl/-7,8-methylenedioxy-5h-2,3-benzodiazepine derivatives, acid addicional salts and pharmaceutical compositions containing them
US5639751A (en) * 1990-12-21 1997-06-17 Cyogyszerkutato Intezet Kft N-acyl-2,3-benzodiazepine derivatives for treating acute and chronic neurodegenerative disorders
US6288057B1 (en) * 1994-08-31 2001-09-11 Eli Lilly And Company Physical form of dihydro-2,3-benzodiazepine derivative
TR199501071A2 (tr) * 1994-08-31 1996-06-21 Lilly Co Eli Dihidro-2,3-benzodiazepin türevlerinin üretilmesi icin stereoselektif islem.
PL181112B1 (pl) * 1995-03-28 2001-05-31 Eli Lilly & Co Nowa fizyczna postać (R)-7-acetylo-5-(4-aminofenylo)-8,9-dihydro-8-metylo-7H-1,3-dioksolo[4,5-h] [2,3]-benzodiazepiny, sposób jej otrzymywania oraz kompozycja farmaceutyczna
US5891871A (en) * 1996-03-21 1999-04-06 Cocensys, Inc. Substituted 2,3-benzodiazepin-4-ones and the use thereof
UA67749C2 (uk) * 1997-08-12 2004-07-15 Егіш Дьйодьсердьяр Рт. Похідна 8-заміщеного-9н-1,3-діоксол/4,5-h//2,3/бензодіазепіну з властивостями амра/каїнатного антагоніста, спосіб одержання похідних, фармацевтична композиція (варіанти), спосіб її одержання та спосіб лікування
US6649607B2 (en) * 2001-05-18 2003-11-18 Vela Pharmaceuticals, Inc. Compositions and methods for treating or preventing convulsions or seizures
EP1575521A4 (en) * 2002-12-03 2008-04-30 Vela Acquisition Corp PHARMACEUTICAL COMPOSITION OF 1- (3-HYDROXY-4-METHOXYPHENYL) -4-METHYL-5-ETHYL-7,8-DIMETHOXY-5H-2,3-BENZODIAZEPINE AND ITS USE
US7022700B2 (en) * 2002-12-03 2006-04-04 Vela Pharmaceuticals, Inc. Method of increasing neutrophil production using optically-pure (R)-2,3-benzodiazepines
CA2508542A1 (en) * 2002-12-03 2004-06-17 Vela Pharmaceuticals, Inc. Pharmaceutical composition of 1-(3,4-dimethoxyphenyl)-4-methyl-5-ethyl-7-methoxy-8-hydroxy-5h-2,3-benzodiazepine and uses thereof
US6864251B2 (en) * 2002-12-03 2005-03-08 Vela Pharmaceuticals, Inc. Treatment of LTB4-mediated inflammatory disorders with optically-pure (R)-2,3-benzodiazepines
US6638928B1 (en) 2002-12-03 2003-10-28 Vela Pharmaceuticals, Inc. Treatment of irritable bowel syndrome and nonulcer dyspepsia with substituted 2,3-benzodiazepines
US20040162284A1 (en) * 2003-02-19 2004-08-19 Harris Herbert W. Method of lowering body temperature with (S) tofisopam
US20040224943A1 (en) * 2003-02-19 2004-11-11 Leventer Steven M. Method of lowering body temperature with (R) - 2,3-benzodiazepines
CA2525273C (en) * 2003-05-16 2012-04-17 Vela Pharmaceuticals, Inc. Treatment of gastrointestinal dysfunction and related stress with an enantiomerically-pure (r) 2,3-benzodiazepine
US20070021412A1 (en) * 2003-05-16 2007-01-25 Vela Pharmaceuticals, Inc. Treatment of gastrointestinal dysfunction and related stress with an enantiomerically-pure (S) 2,3-benzodiazepine
US20040254173A1 (en) * 2003-06-13 2004-12-16 Leventer Steven M. Modulation of dopamine responses with substituted (S)-2,3-benzodiazepines
US20050096464A1 (en) * 2003-10-30 2005-05-05 Heikki Heikkila Separation process
EP4197536A1 (en) * 2021-12-20 2023-06-21 Universitat de València Haloperidol for use in the treatment of spinal muscular atrophy

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU186760B (en) * 1981-03-12 1985-09-30 Gyogyszerkutato Intezet Process for preparing 3,4-dihydro-5h-2,3-aenzodiazepine derivatives
DE3319491A1 (de) * 1982-06-19 1983-10-13 Alps Electric Co., Ltd., Tokyo Papierfuehrungsmechanismus fuer schreibgeraete
HU191698B (en) * 1984-07-27 1987-03-30 Gyogyszerkutato Intezet Process for producing new 1-aryl-5h-2beta-benzodiazepines

Also Published As

Publication number Publication date
NL8701909A (nl) 1988-03-01
SE467357B (sv) 1992-07-06
AU596206B2 (en) 1990-04-26
ES2004985A6 (es) 1989-02-16
DE3727226A1 (de) 1988-02-18
FI85706B (fi) 1992-02-14
NO873426L (no) 1988-02-16
FI85706C (fi) 1992-05-25
FI873525A0 (fi) 1987-08-14
NO164656C (no) 1990-10-31
CS600787A2 (en) 1988-08-16
GB2194236A (en) 1988-03-02
NO873426D0 (no) 1987-08-14
GB2194236B (en) 1990-03-21
SE8703169L (sv) 1988-02-16
DK424887A (da) 1988-02-16
HU198494B (en) 1989-10-30
DK164555B (da) 1992-07-13
ATA202187A (de) 1993-06-15
PL148535B1 (en) 1989-10-31
GB8719265D0 (en) 1987-09-23
YU151487A (en) 1988-12-31
YU46223B (sh) 1993-05-28
FI873525A7 (fi) 1988-02-16
US4835152A (en) 1989-05-30
BE1002415A4 (fr) 1991-02-05
DD265627A5 (de) 1989-03-08
JPS6399073A (ja) 1988-04-30
RU1779251C (ru) 1992-11-30
IT8721667A0 (it) 1987-08-14
FR2602773B1 (fr) 1990-11-02
CA1284322C (en) 1991-05-21
NO164656B (no) 1990-07-23
DK424887D0 (da) 1987-08-14
SE8703169D0 (sv) 1987-08-14
CH673652A5 (en, 2012) 1990-03-30
IT1222508B (it) 1990-09-05
FR2602773A1 (fr) 1988-02-19
AU7688087A (en) 1988-02-18
DK164555C (da) 1992-11-30
HUT47287A (en) 1989-02-28

Similar Documents

Publication Publication Date Title
CS264150B2 (en) Process for preparing new 1-/4-aminophenyl/-4-methyl-7,8-methylendioxy-3,4-dihydro-5h-2,3-benzodiazepine
DE69518373T2 (de) Neue Zusammensetzungen, die Sertralin und einem 5-HT1D-Rezeptoragonisten oder Antagonisten enthalten
RU2142951C1 (ru) Соединения (r)-5-карбамоил-8-фтор-3-n,n-дизамещенные-амино-3,4-дигидро-2h-1-бензопираны, фармацевтическая композиция, способ лечения и способы получения соединений
DE69922024T2 (de) Pyrrolochinoline zur Behandlung von Fettleibigkeit
BG64176B1 (bg) Бензил(илиден)лактамови производни, тяхното получаване и използването им като селективни антагонисти/агонисти на 5-нт1а и/или 5-нт1d рецептори
HRP20000494A2 (en) Pharmaceutically active morpholinol
MXPA01005905A (es) Ligandos selectivos de receptores de 5-ht6.
US20040229865A1 (en) Cycloocta[b][1,4]diazepino[6,7,1-hi]indoles and derivatives
AU2016302755A1 (en) 5-HT2C receptor agonists and compositions and methods of use
EP0970957B1 (en) Diaza-spiro[3,5] nonane derivatives
KR100417506B1 (ko) 항우울 치료를 위한 5ｈｔ1 길항제
AU2002337863B2 (en) Carbinols for the treatment of neuropathic dysfunction
JP2004513116A (ja) 疼痛治療のためのｎ−型カルシウムチャンネル拮抗薬
DE69406678T2 (de) Heterozyclische amine mit zns-wirksamkeit
CZ291276B6 (cs) 3-Substituované deriváty 3H-2,3-benzodiazepinu, způsob jejich výroby, jejich pouľití v léčivech a farmaceutický prostředek tyto látky obsahující
AP338A (en) A carbamoylchroman compound as selective 5-hydroxytryptamine.
EP1001956B1 (en) 2,3-benzodiazepine derivatives
LU82235A1 (fr) Phenylmorphanes, intermediaires et procedes de synthese, et leur utilisation therapeutique
KR20200060404A (ko) 신규한 염
JPH06102660B2 (ja) 新規なモルホリン誘導体およびこれらの誘導体を含有する医薬組成物
CZ332195A3 (en) (+)- and (-)-enantiomer of 4-(5-fluoro-2,3-dihydro-1h-inden-2-yl)-1h-imidazole and process for preparing thereof
US3968230A (en) Compositions containing benzodiazepindiones and method of use
NZ227299A (en) Hydroxy- or keto-amine derivatives and pharmaceutical compositions
MXPA01006669A (en) 5ht1 antagonists for antidepressant therapy